US FDA approves Pfizer’s COVID-19 booster shot for 12 to 15-year-olds

0
74

The US Food and Drug Administration on Monday licensed using the third dose of the Pfizer and BioNTech COVID-19 vaccine for kids aged 12 to fifteen, and shortened the time for all. booster photographs 6 months to five months after the first dose.

The company additionally licensed a 3rd shot in youngsters aged 5 to 11, who’re immunocompromised. The FDA mentioned it reviewed printed information and real-world proof, together with information from greater than 6,300 people, on the protection of booster doses offered by Israel’s Ministry of Health. to age 15 who acquired the Pfizer shot.

The Omicron variant is inflicting an increase in international COVID-19 circumstances and well being officers have warned that its extraordinarily excessive transmission potential might have an effect on a number of well being methods.

Laboratory assessments have proven that two doses of the Pfizer-BioEntech and Moderna vaccines produced a low immune response in opposition to Omicron, whereas the boosters seemed to be protecting in opposition to the extremely mutated model.

,
With inputs from TheIndianEXPRESS

Leave a reply

Please enter your comment!
Please enter your name here